24 May 2013
Keywords: organon, stops, livial, trial, recurrence, trend, dutch
Article | 28 May 2007
Dutch drugmaker Organon has decided to discontinue the LIBERATE trial, which is assessing its approved hormone therapy Livial (tibolone) for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 May 2007
21 May 2007
4 June 2007
© 2013 thepharmaletter.com